Ixchiq: World’s First Chikungunya Vaccine Approved By FDA | Vaccine For Chikungunya | US News
This single-dose vaccine is intended for individuals aged 18 and older at a heightened risk of Chikungunya virus exposure, transmitted primarily through infected mosquitoes.
Published Date - 13 November 2023, 04:40 PM
Hyderabad: The US Food and Drug Administration (FDA) has granted approval for Ixchiq, the world’s first chikungunya vaccine developed by French biotech company Valneva.
This single-dose vaccine is intended for individuals aged 18 and older at a heightened risk of Chikungunya virus exposure, transmitted primarily through infected mosquitoes.
